KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bilibili (BILI) Cash & Equivalents (2016 - 2025)

Bilibili filings provide 10 years of Cash & Equivalents readings, the most recent being $1.7 billion for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 20.39% to $1.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 20.39% increase, with the full-year FY2025 number at $1.7 billion, up 340.85% from a year prior.
  • Cash & Equivalents reached $1.7 billion in Q4 2025 per BILI's latest filing, up from $1.4 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $1.7 billion in Q4 2025, with the low at $998.9 million in Q4 2023.
  • A 5-year average of $1.4 billion and a median of $1.4 billion in 2024 define the central range for Cash & Equivalents.
  • Year-over-year, Cash & Equivalents soared 66.69% in 2021 and then plummeted 30.17% in 2023.
  • Year by year, Cash & Equivalents stood at $1.2 billion in 2021, then rose by 21.55% to $1.4 billion in 2022, then tumbled by 30.17% to $998.9 million in 2023, then skyrocketed by 42.85% to $1.4 billion in 2024, then rose by 20.39% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for BILI's Cash & Equivalents are $1.7 billion (Q4 2025), $1.4 billion (Q4 2024), and $998.9 million (Q4 2023).